r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

KT

Kim R. Tsuchimoto

Insider · Director · MNPR

Kim R. Tsuchimoto files insider transactions with the SEC as a chief financial officer of Monopar Therapeutics (MNPR). We hold 2 disclosed purchases and sales filed since 31 May 2006, 2 of them in the last 90 days.

  • Files forMNPR
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure28 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 18 December 2019 — 26 August 2026Chief Financial Officer · Monopar Therapeutics (MNPR)82 Form 4 lines · source: SEC Form 4
  • Filed 28 August 2018 — 28 August 2018Chief Financial Officer · Monopar Therapeutics (NONE)2 Form 4 lines · source: SEC Form 4
  • Filed 17 May 2007 — 25 September 2012Chief Financial Officer · Raptor Pharmaceutical (RPTP)28 Form 4 lines · source: SEC Form 4
  • Filed 29 September 2009 — 29 September 2009Chief Financial Officer · Raptor Pharmaceutical (RPTPD)3 Form 4 lines · source: SEC Form 4
  • Filed 26 May 2006 — 26 May 2006CFO, Treasurer and Secretary · Highland Clan Creations (HCLN)1 Form 4 line · source: SEC Form 4

Everything they disclosed

116 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.